Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prostate cancer and the genomic revolution: Advances using microarray analyses.

Alfonso Calvo1, Oscar Gonzalez-Moreno, Cheol-Yong Yoon

  • 1Laboratory of Cell Regulation and Carcinogenesis, National Cancer Institute, NIH, Building 41, Bethesda, MD 20892, USA.

Mutation Research
|June 14, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term survival and biomarkers of immunotherapy in small cell lung cancer: a systematic review.

Translational lung cancer research·2026
Same author

Loss of PTEN as an Independent Poor Prognosis Indicator in Lung Adenocarcinoma, but Not in Squamous Cell Carcinoma, Is Associated with an Immunosuppressive Tumor Microenvironment and Distinct Co-Mutational Profiles.

Medical sciences (Basel, Switzerland)·2026
Same author

A New Predictive Model for Radiation Necrosis Risk Based on PTV-Enriched Blood Inflammatory Biomarkers in Patients With Brain Metastases Treated With Stereotactic Radiosurgery.

International journal of radiation oncology, biology, physics·2026
Same author

Establishment and characterization of an orthotopic implanted lung cancer model to mimic human tumor structure, microenvironment, and metastatic spread.

Translational lung cancer research·2025
Same author

Genome-wide methylation analysis of circulating cell-free DNA identifies an episignature in lung cancer: validation of EMP2 as a potential biomarker.

Clinical epigenetics·2025
Same author

Protocol to develop a 3D mouse autologous lung tumor-immune spheroid co-culture model to advance radiotherapy-based treatments.

STAR protocols·2025
Same journal

Monoallelic germline RAD51C, RAD51D, and BRIP1 variants in hereditary cancer testing: Variant spectrum and clinical counselling implications.

Mutation research·2026
Same journal

Prediction of hepatocellular carcinoma associated biomarkers in TP53 gene; A comprehensive in silico analysis.

Mutation research·2026
Same journal

IDH1 mutation promotes angiogenesis via upregulation of hypoxia inducible factor 1 alpha in glial tumors.

Mutation research·2026
Same journal

Targeting overexpressed oncogenes in esophageal cancer through miRNA-mediated gene silencing: Insights from binding affinity and thermodynamic profiling.

Mutation research·2026
Same journal

The active compound quercetin from Polygonum cuspidatum targets COL3A1 to enhance CD8⁺ T cell cytotoxicity in gastric cancer.

Mutation research·2026
Same journal

E2F1 promotes LIHC malignant phenotype via NEK2-mediated Wnt/β-catenin and Notch activation and EMT.

Mutation research·2026
See all related articles

Microarray analysis is revealing new genes in prostate cancer development. Combining this with other high-throughput methods offers deeper insights into cancer and targeted therapies.

Area of Science:

  • Oncology
  • Genomics
  • Molecular Biology

Background:

  • Prostate cancer research is advancing with new molecular profiling techniques.
  • Understanding the genetic and molecular basis of prostate cancer is crucial for effective treatment.

Purpose of the Study:

  • To explore the role of microarray analysis in identifying novel genes in prostate cancer.
  • To investigate how integrating various high-throughput techniques can enhance understanding of prostate cancer development and treatment.

Main Methods:

  • Utilizing microarray analysis to establish molecular portraits of prostate cancer.
  • Employing high-throughput techniques such as proteomics, tissue arrays, and gene promoter-methylation analysis.
  • Characterizing animal models of prostate cancer using high-throughput methods.

Related Experiment Videos

Main Results:

  • Identification of numerous novel genes involved in prostate cancer carcinogenesis.
  • Functional analyses of newly discovered genes are underway.
  • High-throughput techniques are providing comprehensive insights into prostate cancer development.

Conclusions:

  • Microarray analysis and integrated high-throughput methods are key to understanding prostate cancer.
  • These technologies promise to advance molecular medicine and gene-targeted therapies for prostate cancer.
  • Proteomic technologies offer precise insights into cellular alterations during prostate carcinogenesis.